Company intelligence / Profile preview

PainCeptor Pharma

Montreal, Quebec, Canadapainceptor.com ↗

Ownership: Private
Employees: ~45
Development stage: Other

Overview

PainCeptor Pharma advanced two key pain therapeutic programs targeting ASIC1 and NGF/p75 to preclinical lead candidate nomination between 2004-2007, but clinical development was discontinued by 2016 and the company is no longer active.[1][5]

Therapeutic areas: Neurology
Modalities: Small molecule
Industry: Biotech

Partnerships

NeuroSearch

Beyond the preview

Go deeper on PainCeptor Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PainCeptor Pharma.